NCT05477394View on ClinicalTrials.gov

Metabolic Syndrome as Prognostic Factor for Outcome of Sever SARS-COV-2 Cases.

CompletedOBSERVATIONAL

Enrollment

90

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 30, 2021

Study Completion Date

January 30, 2022

Conditions

COVID-19

Trial Locations (1)

Unknown

Ain Shams University, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT05477394 - Metabolic Syndrome as Prognostic Factor for Outcome of Sever SARS-COV-2 Cases. | Biotech Hunter | Biotech Hunter